In this Issue
By Allen C. Ho, MD and Robert L. Avery, MD
BUSINESS OF RETINA
By Nikolas J.S. London, MD; Trexler M. Topping, MD; and John W. Kitchens, MD
Efficient collecting, transferring, and managing of data during a clinical trial is important and helps advance the drug development process.
By Aron Shapiro and Dale Usner, PhD
Most patients with retinoschisis will remain asymptomatic without treatment. It is important to know when and how to intervene.
By David C. Reed, MD; Omesh P. Gupta, MD, MBA; and Sunir J. Garg, MD
By Riva Lee Asbell
By Gurkan Erdogan, MD, and Umut Onur, MD, FEBO
Micropulse laser may extend anti-VEGF treatment intervals in several retinal diseases.
By Ahad Mahootchi, MD
Where do the various treatment options fit in managing patients with diabetic macular edema?
An Interview with David Eichenbaum, MD
Pars plana vitrectomy, membrane peel, endolaser ablation, and transvitreal biopsy in the primary management of uveal malignant melanoma.
By Victor M. Villegas, MD; S.K. Steven Houston III, MD; Aaron Gold, OD; Andrea Wildner, CRA; Fiona Ehlies, CDOS; Jennifer Thomson, CRA; Azeema Latiff, BSN, MBA; and Timothy G. Murray, MD, MBA
Evidence is mounting for the efficacy of this approach.
By S.K. Steven Houston III, MD; Victor M. Villegas, MD; Aaron Gold, OD; and Timothy G. Murray, MD, MBA
The ultrasound-based technique has not been supplanted by newer imaging technologies.
By Mario Danilo de la Torre Estremadoyro, MD
Smoking has ill effects on far more than just the lungs.
By Carol L. Shields, MD
Monitoring nevi in annual examinations can help find and treat tumors sooner.
By Komal B. Desai, BA, MD
Andrew Lam, MD, is a partner with New England Retina Consultants in Springfield, Massachusetts, and an Assistant Professor of Ophthalmology at Tufts University School of Medicine.